Advertisement
For patients with relapsed multiple myeloma

Cardiovascular AEs Common With Carfilzomib in Multiple Myeloma

0
Patients with relapsed multiple myeloma experiencing CVAEs had inferior survival
Sudden unexpected death in epilepsy can occur across the full spectrum of epilepsies

Sudden Death Can Occur in Full Spectrum of Epilepsies

0
Only 37 percent of patients with sudden unexpected death in epilepsy took last dose of antiseizure meds
Patients undergoing partial knee replacement have a reduced risk for venous thromboembolism and opioid use in months 3 to 12 after surgery

VTE Risk Reduced With Partial Knee Replacement

0
But risk for five-year revision higher for those undergoing partial versus total knee replacement
Victoza (liraglutide) injection is now approved to treat type 2 diabetes in children 10 years and older

FDA Approves Victoza Injection for Children 10 Years and Older

0
~64 percent of children treated with Victoza achieved HbA1c levels less than 7 percent
The addition of bevacizumab to carboplatin/pemetrexed is associated with improved overall survival among patients with advanced non-small cell lung cancer

Adding Bevacizumab Improves Overall Survival in NSCLC

0
Addition of bevacizumab to carboplatin/pemetrexed beneficial in advanced non-small cell lung cancer
For children with type 1 diabetes

Pediatric T1DM Medication Adherence Drops on Weekends, Holidays

0
Clinical characteristics, socioeconomic status, adverse effects do not predict adherence
Specific patterns of opioid administration to opioid-naive inpatients are associated with risk for long-term use after discharge

Patterns of Inpatient Opioid Use Linked to Long-Term Use

0
Outpatient use at 90 days was seen for 5.9 and 3.0 percent of patients with and without inpatient use
Use of pantoprazole for up to three years to prevent upper gastrointestinal events in patients receiving anticoagulant therapy with aspirin and/or rivaroxaban has a similar safety profile to placebo except for an increased risk for enteric infections

PPI Use for Up to Three Years Safe During Anticoagulant Tx

0
Safety profile did not differ for pantoprazole versus placebo except greater risk for enteric infections
For patients with mild-to-moderate Alzheimer disease

Nilvadipine Increases Cerebral Blood Flow in the Hippocampus

0
CBF did not significantly change in posterior cingulate cortex, other regions of interest in Alzheimer disease

American Diabetes Association, June 7-11

0
The American Diabetes Association 79th Scientific Sessions The annual meeting of the American Diabetes Association was held from June 7 to 11 in...